Indrani Chakraborty has extensive experience in the biopharmaceutical industry, with a background in antibody development and biophysical and bioanalytical work. Indrani has held various positions at Gator Bio, Bristol-Myers Squibb, Medarex Inc, and Scios Inc, where Indrani has contributed to research and development as a research scientist and staff RA. Their education includes a degree from North Dakota State University.
January 1, 2023 - present
July, 2021
January, 2018